Alendronate-associated Polyarticular Synovitis: A Case Report

被引：0
作者：
Sirin, Busra [1 ]
Kesiktas, Fatma Nur [1 ]
机构：
[1] Istanbul Phys Med & Rehabil Training & Res Hosp, Istanbul, Turkiye
来源：
TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS | 2024年 / 30卷 / 01期
关键词：
Osteoporosis; synovitis; alendronate; bisphosphonate; BISPHOSPHONATES; RISK;
D O I：
10.4274/tod.galenos.2023.75317
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Osteoporosis is a commonly observed systemic metabolic disease characterized by a decrease in bone mineral density and an increased risk of fractures worldwide. Bisphosphonates are commonly preferred for its prevention and treatment. Among the side effects of bisphosphonates used orally and parenterally are gastrointestinal symptoms, musculoskeletal pains, flu -like syndrome, and an increase in acute -phase reactants. In this case report, a rare side effect observed during alendronate treatment, polyarticular synovitis, will be presented.
引用
收藏
页码：64 / 67
页数：4
相关论文
共 23 条
  • [1] Efficacy of Strontium Ranelate in Combination with a D-Hormone Analog for the Treatment of Postmenopausal Osteoporosis
    Abboskhujaeva L.S.
    Ismailov S.I.
    Alikhanova N.M.
    [J]. Drugs in R&D, 2014, 14 (4) : 315 - 324
  • [2] [Anonymous], 2001, Drug Ther Bull, V39, P68
  • [3] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
    Black, Dennis M.
    Delmas, Pierre D.
    Eastell, Richard
    Reid, Ian R.
    Boonen, Steven
    Cauley, Jane A.
    Cosman, Felicia
    Lakatos, Peter
    Leung, Ping Chung
    Man, Zulema
    Mautalen, Carlos
    Mesenbrink, Peter
    Hu, Huilin
    Caminis, John
    Tong, Karen
    Rosario-Jansen, Theresa
    Krasnow, Joel
    Hue, Trisha F.
    Sellmeyer, Deborah
    Eriksen, Erik Fink
    Cummings, Steven R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) : 1809 - 1822
  • [4] Risk of mortality following clinical fractures
    Cauley, JA
    Thompson, DE
    Ensrud, KC
    Scott, JC
    Black, D
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 (07) : 556 - 561
  • [5] Pharmacology of bisphosphonates
    Cremers, Serge
    Drake, Matthew T.
    Ebetino, F. Hal
    Bilezikian, John P.
    Russell, R. Graham G.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (06) : 1052 - 1062
  • [6] The effects of antifracture therapies on the components of bone strength: Assessment of fracture risk today and in the future
    Davison, K. Shawn
    Siminoski, Kerry
    Adachi, J. D.
    Hanley, David A.
    Goltzman, David
    Hodsman, Anthony B.
    Josse, Robert
    Kaiser, Stephanie
    Olszynski, Wojciech P.
    Papaioannou, Alexandra
    Ste-Marie, Louis-George
    Kendler, David L.
    Tenenhouse, Alan
    Brown, Jacques P.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2006, 36 (01) : 10 - 21
  • [7] Frederiksen Louise, 2007, Ugeskr Laeger, V169, P1583
  • [8] Possible alendronate-induced polyarticular synovitis
    Gokkus, K.
    Yazicioglu, G.
    Sagtas, E.
    Uyan, A.
    Aydin, A. T.
    [J]. JOURNAL OF POSTGRADUATE MEDICINE, 2016, 62 (02) : 126 - 128
  • [9] Jones DPG, 2008, J RHEUMATOL, V35, P537
  • [10] Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0
123